Back

Endothelial-Mesenchymal Transition: miR-101 as a new target to treat intimal hyperplasia

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Vascular biology and remodelling Vascular remodelling ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Byambasuren Vanchin

Mongolian National University of Medical Sciences, Ulaanbaatar (Mongolia)

14 More presentations in this session

Presentation thumbnail
Doctor J. Dutzmann (Halle, DE)
Abstract
Presentation thumbnail
Doctor J. Daniel (Giessen, DE)
Abstract
Presentation thumbnail
Mr R. Musmann
Abstract
Presentation thumbnail
Miss M. Jaeger (Mainz, DE)
Abstract
Presentation thumbnail
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Vascular biology and remodelling

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Potential implication of microRNA21 and matrix metalloproteinases in myocardial and arterial function in patients with coronary disease and type-2 diabetes at baseline and 1-year follow up
13 December 2025
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023
thumbnail
Congress Presentation
SMAD3 silencing induces Epithelial-to-Mesenchymal Transition (EMT) towards cardiac pericyte progenitors with proangiogenic potential in hiPSC-derived epicardial cells
30 August 2024
thumbnail
Congress Presentation
Dysregulation of the endomembrane homeostasis triggers vascular smooth muscle cell phenotype switching
1 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources